Scientists track chemical storm in blood to predict cancer treatment side effects
NCT ID NCT05707286
Summary
This study aimed to understand when and how the body's inflammatory chemicals change during a common cancer treatment called immune checkpoint inhibitor therapy. Researchers followed 98 adults with cancers like melanoma and lung cancer, taking their blood at specific times after starting treatment. The goal was to learn the timing of these chemical changes to better predict and manage treatment side effects and potential drug interactions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, 46202, United States
Conditions
Explore the condition pages connected to this study.